guest ::
| Home > Publications database > Absolute serum neurofilament light chain levels and its early kinetics predict brain injury after out-of-hospital cardiac arrest > print |
| Home > Publications database > Absolute serum neurofilament light chain levels and its early kinetics predict brain injury after out-of-hospital cardiac arrest > print |
| 001 | 904377 | ||
| 005 | 20250813092739.0 | ||
| 024 | 7 | _ | |2 doi |a 10.1007/s00415-021-10722-3 |
| 024 | 7 | _ | |2 ISSN |a 0012-1037 |
| 024 | 7 | _ | |2 ISSN |a 0340-5354 |
| 024 | 7 | _ | |2 ISSN |a 0939-1517 |
| 024 | 7 | _ | |2 ISSN |a 1432-1459 |
| 024 | 7 | _ | |2 ISSN |a 1619-800X |
| 024 | 7 | _ | |2 Handle |a 2128/30815 |
| 024 | 7 | _ | |2 altmetric |a altmetric:112416305 |
| 024 | 7 | _ | |2 pmid |a pmid:34328545 |
| 024 | 7 | _ | |2 WOS |a WOS:000679613600002 |
| 037 | _ | _ | |a FZJ-2021-05947 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |0 P:(DE-HGF)0 |a Adler, Christoph |b 0 |
| 245 | _ | _ | |a Absolute serum neurofilament light chain levels and its early kinetics predict brain injury after out-of-hospital cardiac arrest |
| 260 | _ | _ | |a Berlin |b Springer |c 2022 |
| 264 | _ | 1 | |2 Crossref |3 online |b Springer Science and Business Media LLC |c 2021-07-30 |
| 264 | _ | 1 | |2 Crossref |3 print |b Springer Science and Business Media LLC |c 2022-03-01 |
| 264 | _ | 1 | |2 Crossref |3 print |b Springer Science and Business Media LLC |c 2022-03-01 |
| 336 | 7 | _ | |2 DRIVER |a article |
| 336 | 7 | _ | |2 DataCite |a Output Types/Journal article |
| 336 | 7 | _ | |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |a Journal Article |b journal |m journal |s 1646143726_3719 |
| 336 | 7 | _ | |2 BibTeX |a ARTICLE |
| 336 | 7 | _ | |2 ORCID |a JOURNAL_ARTICLE |
| 336 | 7 | _ | |0 0 |2 EndNote |a Journal Article |
| 520 | _ | _ | |a AbstractObjectives: To test if the early kinetics of neurofilament light (NFL) in blood adds to the absolute values of NFL in the prediction of outcome, and to evaluate if NFL can discriminate individuals with severe hypoxic-ischemic brain injury (sHIBI) from those with other causes of poor outcome after out-of-hospital cardiac arrest (OHCA).Design and setting: Monocentric retrospective study involving individuals following non-traumatic OHCA between April 2014 and April 2016. NFL concentrations were determined on a SiMoA HD-1 device using NF-Light Advantage Kits.Participants: Of 73 patients screened, 53 had serum samples available for NFL measurement at three timepoints (after 3, 24, and 48 h of admission). Of these 53 individuals, 43.4% had poor neurologic outcome at discharge as assessed by Glasgow-Pittsburgh cerebral performance categories, and, according to a current prognostication algorithm, poor outcome due to sHIBI in 20.7%.Main outcome measure: Blood NFL and its early kinetics for prognostication of outcome and prediction of sHIBI after OHCA.Results: An absolute NFL > 508.6 pg/ml 48 h after admission, or a change in NFL > 494 pg/ml compared with an early baseline value predicted outcome, and discriminated severe sHIBI from other causes of unfavorable outcome after OHCA with high sensitivity (100%, 95%CI 70.0-100%) and specificity (91.7%, 95%CI 62.5-100%).Conclusions: Not only absolute values of NFL, but also early changes in NFL predict the outcome following OHCA, and may differentiate sHIBI from other causes of poor outcome after OHCA with high sensitivity and specificity. Our study adds to published data, overall corroborating that NFL measured in blood should be implemented in prognostication algorithms used in clinical routine.Keywords: Brain hypoxia; Cerebral hypoxia; Hypoxic–ischemic brain injury; NFL. |
| 536 | _ | _ | |0 G:(DE-HGF)POF4-5252 |a 5252 - Brain Dysfunction and Plasticity (POF4-525) |c POF4-525 |f POF IV |x 0 |
| 542 | _ | _ | |2 Crossref |i 2021-07-30 |u https://creativecommons.org/licenses/by/4.0 |
| 542 | _ | _ | |2 Crossref |i 2021-07-30 |u https://creativecommons.org/licenses/by/4.0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Onur, Oezguer A. |b 1 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Braumann, Simon |b 2 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Gramespacher, Hannes |b 3 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Bittner, Stefan |b 4 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Falk, Steffen |b 5 |
| 700 | 1 | _ | |0 P:(DE-Juel1)131720 |a Fink, Gereon R. |b 6 |u fzj |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Baldus, Stephan |b 7 |
| 700 | 1 | _ | |0 0000-0002-3510-9255 |a Warnke, Clemens |b 8 |e Corresponding author |
| 773 | 1 | 8 | |2 Crossref |3 journal-article |a 10.1007/s00415-021-10722-3 |b Springer Science and Business Media LLC |d 2021-07-30 |n 3 |p 1530-1537 |t Journal of Neurology |v 269 |x 0340-5354 |y 2021 |
| 773 | _ | _ | |0 PERI:(DE-600)1421299-7 |a 10.1007/s00415-021-10722-3 |n 3 |p 1530-1537 |t Journal of neurology |v 269 |x 0340-5354 |y 2022 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/904377/files/Adler2022_Article_AbsoluteSerumNeurofilamentLigh.pdf |y OpenAccess |
| 909 | C | O | |o oai:juser.fz-juelich.de:904377 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)131720 |a Forschungszentrum Jülich |b 6 |k FZJ |
| 913 | 1 | _ | |0 G:(DE-HGF)POF4-525 |1 G:(DE-HGF)POF4-520 |2 G:(DE-HGF)POF4-500 |3 G:(DE-HGF)POF4 |4 G:(DE-HGF)POF |9 G:(DE-HGF)POF4-5252 |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |v Decoding Brain Organization and Dysfunction |x 0 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |
| 915 | _ | _ | |0 StatID:(DE-HGF)1030 |2 StatID |a DBCoverage |b Current Contents - Life Sciences |
| 915 | _ | _ | |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |a Creative Commons Attribution CC BY 4.0 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0600 |2 StatID |a DBCoverage |b Ebsco Academic Search |
| 915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b J NEUROL : 2015 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |
| 915 | _ | _ | |0 StatID:(DE-HGF)0110 |2 StatID |a WoS |b Science Citation Index |
| 915 | _ | _ | |0 StatID:(DE-HGF)0111 |2 StatID |a WoS |b Science Citation Index Expanded |
| 915 | _ | _ | |0 StatID:(DE-HGF)9900 |2 StatID |a IF < 5 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0510 |2 StatID |a OpenAccess |
| 915 | _ | _ | |0 StatID:(DE-HGF)0030 |2 StatID |a Peer Review |b ASC |
| 915 | _ | _ | |0 StatID:(DE-HGF)0310 |2 StatID |a DBCoverage |b NCBI Molecular Biology Database |
| 915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |
| 915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |
| 915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Thomson Reuters Master Journal List |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-3-20090406 |k INM-3 |l Kognitive Neurowissenschaften |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-Juel1)INM-3-20090406 |
| 980 | 1 | _ | |a FullTexts |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1007/s00134-020-06224-x |u Sandroni C, Grippo A, Nolan JP (2020) ERC-ESICM guidelines for prognostication after cardiac arrest: time for an update. Intensive Care Med 46:1901–1903. https://doi.org/10.1007/s00134-020-06224-x |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1016/j.resuscitation.2017.05.014 |u Dragancea I, Wise MP, Al-Subaie N, Cranshaw J, Friberg H, Glover G, Pellis T, Rylance R, Walden A, Nielsen N, Cronberg T, investigators TTM (2017) Protocol-driven neurological prognostication and withdrawal of life-sustaining therapy after cardiac arrest and targeted temperature management. Resuscitation 117:50–57. https://doi.org/10.1016/j.resuscitation.2017.05.014 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1097/CCM.0000000000000540 |u Mulder M, Gibbs HG, Smith SW, Dhaliwal R, Scott NL, Sprenkle MD, Geocadin RG (2014) Awakening and withdrawal of life-sustaining treatment in cardiac arrest survivors treated with therapeutic hypothermia*. Crit Care Med 42:2493–2499. https://doi.org/10.1097/CCM.0000000000000540 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1016/j.resuscitation.2021.02.012 |u Nolan JP, Sandroni C, Bottiger BW, Cariou A, Cronberg T, Friberg H, Genbrugge C, Haywood K, Lilja G, Moulaert VRM, Nikolaou N, Mariero Olasveengen T, Skrifvars MB, Taccone F, Soar J (2021) European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: post-resuscitation care. Resuscitation 161:220–269. https://doi.org/10.1016/j.resuscitation.2021.02.012 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1038/s41582-018-0058-z |u Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas F, Petzold A, Blennow K, Zetterberg H, Kuhle J (2018) Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 14:577–589. https://doi.org/10.1038/s41582-018-0058-z |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1016/j.ebiom.2020.102807 |u Bittner S, Steffen F, Uphaus T, Muthuraman M, Fleischer V, Salmen A, Luessi F, Berthele A, Klotz L, Meuth SG, Bayas A, Paul F, Hartung HP, Linker R, Heesen C, Stangel M, Wildemann B, Then Bergh F, Tackenberg B, Kuempfel T, Weber F, Zettl UK, Ziemann U, Tumani H, Groppa S, Muhlau M, Lukas C, Hemmer B, Wiendl H, Gold R, Zipp F, consortium K (2020) Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study. EBioMedicine 56:102807. https://doi.org/10.1016/j.ebiom.2020.102807 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1161/STROKEAHA.119.026410 |u Uphaus T, Bittner S, Groschel S, Steffen F, Muthuraman M, Wasser K, Weber-Kruger M, Zipp F, Wachter R, Groschel K (2019) NfL (Neurofilament Light Chain) levels as a predictive marker for long-term outcome after ischemic stroke. Stroke 50:3077–3084. https://doi.org/10.1161/STROKEAHA.119.026410 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1001/jamaneurol.2018.3223 |u Moseby-Knappe M, Mattsson N, Nielsen N, Zetterberg H, Blennow K, Dankiewicz J, Dragancea I, Friberg H, Lilja G, Insel PS, Rylander C, Westhall E, Kjaergaard J, Wise MP, Hassager C, Kuiper MA, Stammet P, Wanscher MCJ, Wetterslev J, Erlinge D, Horn J, Pellis T, Cronberg T (2019) Serum neurofilament light chain for prognosis of outcome after cardiac arrest. JAMA Neurol 76:64–71. https://doi.org/10.1001/jamaneurol.2018.3223 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1016/j.ijcard.2012.12.016 |u Rana OR, Schroder JW, Baukloh JK, Saygili E, Mischke K, Schiefer J, Weis J, Marx N, Rassaf T, Kelm M, Shin DI, Meyer C, Saygili E (2013) Neurofilament light chain as an early and sensitive predictor of long-term neurological outcome in patients after cardiac arrest. Int J Cardiol 168:1322–1327. https://doi.org/10.1016/j.ijcard.2012.12.016 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1007/s00134-020-06218-9 |u Wihersaari L, Ashton NJ, Reinikainen M, Jakkula P, Pettila V, Hastbacka J, Tiainen M, Loisa P, Friberg H, Cronberg T, Blennow K, Zetterberg H, Skrifvars MB, Comacare Study G (2021) Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial. Intensive Care Med 47:39–48. https://doi.org/10.1007/s00134-020-06218-9 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1186/s13054-021-03459-y |u Hunziker S, Quinto A, Ramin-Wright M, Becker C, Beck K, Vincent A, Tisljar K, Disanto G, Benkert P, Leppert D, Pargger H, Marsch S, Raoul S, Peters N, Kuhle J (2021) Serum neurofilament measurement improves clinical risk scores for outcome prediction after cardiac arrest: results of a prospective study. Crit Care 25:32. https://doi.org/10.1186/s13054-021-03459-y |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1186/s13054-018-2042-9 |u Adler C, Heller T, Schregel F, Hagmann H, Hellmich M, Adler J, Reuter H (2018) TIMP-2/IGFBP7 predicts acute kidney injury in out-of-hospital cardiac arrest survivors. Crit Care 22:126. https://doi.org/10.1186/s13054-018-2042-9 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1161/01.CIR.0000147236.85306.15 |u Jacobs I, Nadkarni V, Bahr J, Berg RA, Billi JE, Bossaert L, Cassan P, Coovadia A, D'Este K, Finn J, Halperin H, Handley A, Herlitz J, Hickey R, Idris A, Kloeck W, Larkin GL, Mancini ME, Mason P, Mears G, Monsieurs K, Montgomery W, Morley P, Nichol G, Nolan J, Okada K, Perlman J, Shuster M, Steen PA, Sterz F, Tibballs J, Timerman S, Truitt T, Zideman D, International Liaison Committee on R, American Heart A, European Resuscitation C, Australian Resuscitation C, New Zealand Resuscitation C, Heart, Stroke Foundation of C, InterAmerican Heart F, Resuscitation Councils of Southern A, Arrest ITFoC, Cardiopulmonary Resuscitation O (2004) Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa). Circulation 110:3385–3397: https://doi.org/10.1161/01.CIR.0000147236.85306.15 |
| 999 | C | 5 | |1 B Jennett |2 Crossref |9 -- missing cx lookup -- |a 10.1016/s0140-6736(75)92830-5 |p 480 - |t Lancet |u Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet 1:480–484. https://doi.org/10.1016/s0140-6736(75)92830-5 |v 1 |y 1975 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1016/j.resuscitation.2005.06.005 |u Langhelle A, Nolan J, Herlitz J, Castren M, Wenzel V, Soreide E, Engdahl J, Steen PA, Utstein Consensus S (2005) Recommended guidelines for reviewing, reporting, and conducting research on post-resuscitation care: the Utstein style. Resuscitation 66:271–283. https://doi.org/10.1016/j.resuscitation.2005.06.005 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1001/jama.2016.0287 |u Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:801–810. https://doi.org/10.1001/jama.2016.0287 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1007/s12028-013-9848-8 |u Huntgeburth M, Adler C, Rosenkranz S, Zobel C, Haupt WF, Dohmen C, Reuter H (2014) Changes in neuron-specific enolase are more suitable than its absolute serum levels for the prediction of neurologic outcome in hypothermia-treated patients with out-of-hospital cardiac arrest. Neurocrit Care 20:358–366: https://doi.org/10.1007/s12028-013-9848-8 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1016/0009-8981(89)90268-4 |u Kaiser E, Kuzmits R, Pregant P, Burghuber O, Worofka W (1989) Clinical biochemistry of neuron specific enolase. Clin Chim Acta 183:13–31. https://doi.org/10.1016/0009-8981(89)90268-4 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1161/01.str.30.8.1598 |u Schoerkhuber W, Kittler H, Sterz F, Behringer W, Holzer M, Frossard M, Spitzauer S, Laggner AN (1999) Time course of serum neuron-specific enolase. A predictor of neurological outcome in patients resuscitated from cardiac arrest. Stroke 30:1598–1603. https://doi.org/10.1161/01.str.30.8.1598 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1016/0009-8981(84)90295-x |u Day IN, Thompson RJ (1984) Levels of immunoreactive aldolase C, creatine kinase-BB, neuronal and non-neuronal enolase, and 14–3–3 protein in circulating human blood cells. Clin Chim Acta 136:219–228. https://doi.org/10.1016/0009-8981(84)90295-x |
| 999 | C | 5 | |1 E Kaiser |2 Crossref |9 -- missing cx lookup -- |a 10.1016/0009-8981(89)90268-4 |p 13 - |t Clin Chim Acta |u Kaiser E, Kuzmits R, Pregant P, Burghuber O, Worofka W (1998) Clinical biochemistry of neuron specific enolase. Clin Chim Acta 183:13–31 |v 183 |y 1998 |
| 999 | C | 5 | |1 PJ Marangos |2 Crossref |9 -- missing cx lookup -- |a 10.1111/j.1471-4159.1980.tb09967.x |p 1254 - |t J Neurochem |u Marangos PJ, Campbell IC, Schmechel DE, Murphy DL, Goodwin FK (1980) Blood platelets contain a neurone specific enolase subunit. J Neurochem 34:1254–1258 |v 34 |y 1980 |
| 999 | C | 5 | |1 M Aghabarary |2 Crossref |u Aghabarary M, Dehghan Nayeri N (2016) Medical futility and its challenges: a review study. J Med Ethics Hist Med 9:11 |y 2016 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1136/medethics-2011-100479 |u Jox RJ, Schaider A, Marckmann G, Borasio GD (2012) Medical futility at the end of life: the perspectives of intensive care and palliative care clinicians. J Med Ethics 38:540–545. https://doi.org/10.1136/medethics-2011-100479 |
| 999 | C | 5 | |2 Crossref |9 -- missing cx lookup -- |a 10.1007/s00415-010-5882-z |u Demertzi A, Ledoux D, Bruno MA, Vanhaudenhuyse A, Gosseries O, Soddu A, Schnakers C, Moonen G, Laureys S (2011) Attitudes towards end-of-life issues in disorders of consciousness: a European survey. J Neurol 258:1058–1065. https://doi.org/10.1007/s00415-010-5882-z |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|